Molecular Diagnosis & Therapy

Mol Diagn Ther

1177-1062

1179-2000

Therapeutic Area

Biology, Biotechnology, Diagnostic Imaging, Molecular Medicine, Pharmacology, Pharmacy, Research

Allied Health Professionals, Biologists, Biomedical Engineers/Technologists, Biomedical Researchers, Caregivers, Chemists, Clinicians, Industrial Scientists, Medicinal Chemists, Oncologists, Pathologists, Patients, Pharmaceutical Benefits Managers, Pharmacists, Pharmacologists, Physicians, Physicians - Medicine, Scientists

Molecular Diagnosis & Therapy welcomes current opinion articles on emerging or contentious issues, comprehensive narrative reviews, systematic reviews (as outlined by the PRISMA statement), original research articles (including short communications) and letters to the editor. All manuscripts are subject to peer review by international experts. Topic coverage of the journal includes: - Use of biomarkers to guide drug development and to serve as diagnostics or prognostic tools. - Detection, monitoring, and treatment of molecular causes of disease. - Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects, and/or disease progression. - Drug/diagnostic combinations (theranostics). - Emerging molecular diagnostic tools and technologies. - Pathogen detection and drug resistance analysis. - Ethical and regulatory issues relating to precision medicine. Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Molecular Drugs & Therapy may be accompanied by plain language summaries to assist readers in understanding important medical advances. Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine. Via a program of reviews and original research articles, the journal is focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on the development of companion diagnostic/therapeutic products, along with the analysis of pharmacogenomic data for drug developmentand therapeutic decision making. The journal Also offers the ability to create digital features as well as host them.

No associations affiliated with this journal

Adis, part of Springer Nature

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines